Synapse Wins FDA Nod for ALS Treatment

Synapse Biomedical has received Humanitarian Use Device approval from the Food and Drug Administration for the NeuRx Diaphragm Pacing System in certain ALS patients. The device uses electrical stimulation to exercise the diaphragm of ALS patients, delaying diaphragm atrophy and the need for mechanical ventilation.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail